Intellia Therapeutics, Inc.

Halal Rating :
See Details
Last Price $26.25 Last updated:
Market Cap $2.11b
7D Change 5.19%
1 Year Change -40.3%

Company Overview

  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing
Exchange NASDAQ
Next Earnings Date Feb. 29, 2024

Intellia Therapeutics, Inc., a genome editing company, is focused on developing therapies. The company is headquartered in Cambridge, Massachusetts.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
March 31, 2024 $28.93m $174.03m $12.63m - 43.66% 0.00%
Dec. 31, 2023 $-1917000.0 $175.87m $12.46m $8.83m 649.92% 5.02%
Sept. 30, 2023 $12.99m $172.5m $12.74m - 98.06% 0.00%

Company Impact

Help us evaluate Intellia Therapeutics, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates